303 related articles for article (PubMed ID: 9401793)
1. Lipolytic effects of conventional beta 3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative beta 4-adrenoceptor.
Galitzky J; Langin D; Verwaerde P; Montastruc JL; Lafontan M; Berlan M
Br J Pharmacol; 1997 Nov; 122(6):1244-50. PubMed ID: 9401793
[TBL] [Abstract][Full Text] [Related]
2. Beta-adrenoceptor subtype expression and function in rat white adipocytes.
Germack R; Starzec AB; Vassy R; Perret GY
Br J Pharmacol; 1997 Jan; 120(2):201-10. PubMed ID: 9117110
[TBL] [Abstract][Full Text] [Related]
3. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.
Kaumann AJ; Molenaar P
Br J Pharmacol; 1996 Aug; 118(8):2085-98. PubMed ID: 8864547
[TBL] [Abstract][Full Text] [Related]
4. Further evidence for differences between cardiac atypical beta-adrenoceptors and brown adipose tissue beta3-adrenoceptors in the pithed rat.
Malinowska B; Schlicker E
Br J Pharmacol; 1997 Dec; 122(7):1307-14. PubMed ID: 9421276
[TBL] [Abstract][Full Text] [Related]
5. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
Carpéné C; Galitzky J; Fontana E; Atgié C; Lafontan M; Berlan M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):310-21. PubMed ID: 10344530
[TBL] [Abstract][Full Text] [Related]
6. Determination of beta 3-adrenoceptor mediated lipolysis in human fat cells.
Hoffstedt J; Shimizu M; Sjöstedt S; Lönnqvist F
Obes Res; 1995 Sep; 3(5):447-57. PubMed ID: 8521164
[TBL] [Abstract][Full Text] [Related]
7. Effects of several putative beta 3-adrenoceptor agonists on lipolysis in human omental adipocytes.
Hoffstedt J; Lönnqvist F; Shimizu M; Blaak E; Arner P
Int J Obes Relat Metab Disord; 1996 May; 20(5):428-34. PubMed ID: 8696421
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.
Galitzky J; Reverte M; Portillo M; Carpéné C; Lafontan M; Berlan M
Am J Physiol; 1993 Mar; 264(3 Pt 1):E403-12. PubMed ID: 8096365
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the alpha-adrenoceptor-mediated effects of beta3-adrenoceptor ligands in rat pulmonary artery.
Leblais V; Pourageaud F; Ivorra MD; Marthan R; Muller B
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):535-9. PubMed ID: 16012871
[TBL] [Abstract][Full Text] [Related]
10. Characterization of beta 1- and beta 3-adrenoceptors in intact brown adipocytes of the rat.
D'Allaire F; Atgié C; Mauriège P; Simard PM; Bukowiecki LJ
Br J Pharmacol; 1995 Jan; 114(2):275-82. PubMed ID: 7881727
[TBL] [Abstract][Full Text] [Related]
11. Functional identification of beta3-adrenoceptors in the guinea-pig ileum using the non-selective beta-adrenoceptor antagonist (+/-)-bupranolol.
Horinouchi T; Koike K
J Auton Pharmacol; 2000 Aug; 20(4):253-8. PubMed ID: 11260363
[TBL] [Abstract][Full Text] [Related]
12. Validity of (-)-[3H]-CGP 12177A as a radioligand for the 'putative beta4-adrenoceptor' in rat atrium.
Sarsero D; Molenaar P; Kaumann AJ
Br J Pharmacol; 1998 Feb; 123(3):371-80. PubMed ID: 9504376
[TBL] [Abstract][Full Text] [Related]
13. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
[TBL] [Abstract][Full Text] [Related]
14. Comparison between CL-316243- and CGP-12177A-induced relaxations in isolated canine ureter.
Tomiyama Y; Murakami M; Yamazaki Y; Kojima M; Akahane M
Pharmacology; 2003 Jul; 68(3):140-6. PubMed ID: 12784085
[TBL] [Abstract][Full Text] [Related]
15. Antilipolytic effects of 1,8-naphthyridine derivatives β-adrenoceptor antagonists in rat white adipocytes.
Aljamal JA; Badawneh M
Chem Biol Drug Des; 2017 Jul; 90(1):119-127. PubMed ID: 28054456
[TBL] [Abstract][Full Text] [Related]
16. Direct evidence for the atypical nature of functional beta-adrenoceptors in rat adipocytes.
Hollenga C; Zaagsma J
Br J Pharmacol; 1989 Dec; 98(4):1420-4. PubMed ID: 2575416
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a functional beta 3-adrenoceptor in man.
Lönnqvist F; Krief S; Strosberg AD; Nyberg S; Emorine LJ; Arner P
Br J Pharmacol; 1993 Nov; 110(3):929-36. PubMed ID: 7905344
[TBL] [Abstract][Full Text] [Related]
18. Agonist and antagonist properties of beta 3-adrenoceptors in human omental and mouse 3T3-L1 adipocytes.
Shimizu M; Blaak EE; Lonnqvist F; Gafvels ME; Arner P
Pharmacol Toxicol; 1996 Apr; 78(4):254-63. PubMed ID: 8861784
[TBL] [Abstract][Full Text] [Related]
19. Beta 1-, beta 2- and atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta.
Brawley L; Shaw AM; MacDonald A
Br J Pharmacol; 2000 Feb; 129(4):637-44. PubMed ID: 10683187
[TBL] [Abstract][Full Text] [Related]
20. Functional studies of the first selective beta 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes.
Nisoli E; Tonello C; Landi M; Carruba MO
Mol Pharmacol; 1996 Jan; 49(1):7-14. PubMed ID: 8569714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
